[h=2]Teva Israel has signed a cooperation and marketing agreement with Israeli company Syqe Medical.[/h]
Is the drug industry changing its approach to medical cannabis? This morning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) subsidiary Teva Israel reported signing a cooperation and marketing agreement with the Israeli company Syqe Medical to market the world's first cannabis inhaler. No financial data on the agreement were disclosed.
According to the agreement, Teva Israel will be the exclusive Israel distributor of Syqe's medical cannabis inhaler, while Syqe will be responsible to produce the inhaler and its cartridges. In addition, the two companies will found a support and instruction array for patients and medical staff, to be composed of a dedicated team of nurses.
http://www.globes.co.il/en/article-teva-to-market-the-worlds-first-cannabis-inhaler-1001163430
Is the drug industry changing its approach to medical cannabis? This morning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) subsidiary Teva Israel reported signing a cooperation and marketing agreement with the Israeli company Syqe Medical to market the world's first cannabis inhaler. No financial data on the agreement were disclosed.
According to the agreement, Teva Israel will be the exclusive Israel distributor of Syqe's medical cannabis inhaler, while Syqe will be responsible to produce the inhaler and its cartridges. In addition, the two companies will found a support and instruction array for patients and medical staff, to be composed of a dedicated team of nurses.
http://www.globes.co.il/en/article-teva-to-market-the-worlds-first-cannabis-inhaler-1001163430